Frontlight ResearchEarly access
Lung cancer trials in United States
900 trials · From ClinicalTrials.gov, checked 16 November 2026. Ask the study team whether a trial fits you.
- No phaseTaking peopleA Multicenter Cancer Biospecimen Collection Study
- Where
- San Francisco
- Age
- 18 years and over
- People
- 1,650
- Run by
- Cofactor Genomics, Inc.
See details and how to joinNCT04510129 - Phase 1Taking peopleSafety Study for a Gamma Delta T Cell Product Used With Low Dose Radiotherapy in Patients With Locally Advanced or Metastatic NSCLC or Solid Tumors With Bone Metastases
- Where
- Beverly Hills, Norfolk, Pittsburgh, Tucson, Tyler
- Age
- 18 years and over
- People
- 48
- Run by
- Kiromic BioPharma Inc.
See details and how to joinNCT06069570 - No phaseTaking peopleStudy of Longitudinal Plasma PD-L1 Testing With Immunotherapy in Lung Cancer
- Where
- Kingsport
- People
- 30
- Run by
- Ballad Health
See details and how to joinNCT06849518 - Phase 1/2Taking peopleA Study of GV20-0251 Monotherapy and GV20-0251 in Combination With Pembrolizumab in Participants With Solid Tumor Malignancies
- Where
- Boston, Denver, Detroit, Fairfax, Fort Myers, Houston, Indianapolis, Los Angeles, Nashville, New Haven, New York, Portland
- Age
- 18 years and over
- People
- 365
- Run by
- GV20 Therapeutics
See details and how to joinNCT05669430 - No phaseTaking peopleThe Effect of Beta-glucan in Non-Small Cell Lung Cancer
- Where
- Louisville
- Age
- 18 years and over
- People
- 300
- Run by
- University of Louisville
See details and how to joinNCT00682032 - Phase 1/2Taking peopleA Study of OR502, a Monoclonal Antibody Targeting LILRB2, Alone and in Combination With Anticancer Agents
- Where
- Austin, Fairfax, Irving, San Antonio
- Age
- 18 years and over
- People
- 168
- Run by
- OncoResponse, Inc.
See details and how to joinNCT06090266 - Phase 2Taking peopleA Study of IBI363 in Subjects with Advanced Solid Malignancies
- Where
- Dearborn, Fairway, Houston, Ocala, Plantation, San Francisco, Seattle, Troy
- Age
- 18 years and over
- People
- 178
- Run by
- Innovent Biologics (Suzhou) Co. Ltd.
See details and how to joinNCT06281678 - No phaseTaking peopleComprehensive Outcomes for After Cancer Health
- Where
- Boston, Columbus, Gainesville, Houston, New York, Omaha
- Age
- 18 years and over
- People
- 625
- Run by
- Pack Health
See details and how to joinNCT05349227 - No phaseTaking peopleAnalysis of RATS, VATS and Open Lung Resections After Neoadjuvant Chemo-immunotherapy in Patients Performed in Five Referred Centers
- Where
- Miami, Morgantown, New York
- Age
- 18 years and over
- People
- 140 worldwide
- Run by
- Scientific Institute San Raffaele
See details and how to joinNCT06626243 - Phase 1/2Taking peoplePhase 1a and Phase 2 Study for Safety, Preliminary Efficacy, PK and PD of ST-067
- Where
- Boston, Buffalo, Denver, New Haven, Scottsdale, Tampa
- Age
- 18 years and over
- People
- 316
- Run by
- Simcha IL-18, Inc.
See details and how to joinNCT04787042 - No phaseTaking peopleClinical Utility of Management of Patients With Pulmonary Nodules Using the Percepta Nasal Swab Classifier
- Where
- Baltimore, Bay Pines, Boston, Charleston, Chicago, Cincinnati, Gainesville, Greensboro, Hartford, Kansas City, Lexington, Louisville, Miami, New Orleans, Orlando, Peoria, Rochester, Springfield, Stamford, Toledo, West Islip
- Age
- 29 years to 85 years
- People
- 2,400 worldwide
- Run by
- Veracyte, Inc.
See details and how to joinNCT06426628 - Phase 1/2Taking peopleSplit Course Adaptive Radiation Therapy With Pembrolizumab With/Without Chemotherapy for Treating Stage IV Lung Cancer
- Where
- Nashville
- Age
- 18 years and over
- People
- 25
- Run by
- Vanderbilt-Ingram Cancer Center
See details and how to joinNCT05501665 - No phaseTaking peopleNext Generation Chest X-Ray Tomosynthesis for Screening of Lung Cancer
- Where
- San Diego
- Age
- 30 years to 85 years
- People
- 1,000
- Run by
- University of California, San Diego
See details and how to joinNCT06577883 - No phaseEnrolling by invitationAnalysis of Lung Cancer Tissue With Spatial Frequency Domain Imaging
- Where
- Orange
- Age
- 18 years and over
- People
- 20
- Run by
- University of California, Irvine
See details and how to joinNCT06549088 - Phase 1/2Taking peoplePhase I/II Trial in ES-SCLC to Enhance Response to Atezolizumab Plus Chemotherapy With Total Body Irradiation
- Where
- Nashville
- Age
- 18 years and over
- People
- 18
- Run by
- Vanderbilt-Ingram Cancer Center
See details and how to joinNCT06110572 - No phaseTaking peopleUsing Microbiome to Predict Durvalumab Toxicity in Post- Concurrent Chemoradiation Therapy (CCRT) NSCLC Patients
- Where
- Kansas City, Providence
- Age
- 18 years and over
- People
- 44
- Run by
- Jun Zhang, MD, PhD
See details and how to joinNCT04680377 - Phase 2Not yet taking people in United StatesA Study of Combining Cabozantinib and Atezolizumab for Advanced/Metastatic NSCLC (Cabatezo-1)
- Where
- Kansas City, Lee's Summit, Overland Park
- Age
- 18 years and over
- People
- 40
- Run by
- Jun Zhang, MD, PhD
See details and how to joinNCT05859217 - No phaseTaking peopleUsing Ex Vivo Tumoroids To Predict Immunotherapy Response In NSCLC
- Where
- Fairway, Kansas City
- Age
- 18 years to 110 years
- People
- 25
- Run by
- Jun Zhang, MD, PhD
See details and how to joinNCT05332925 - Phase 2Taking peopleComparing Hypo-fractionated Intensity- Modulated Radiation Therapy to Standard- Fractionated IMRT Along With Chemotherapy and Immunotherapy for Non-Small Cell Lung Cancer
- Where
- Kansas City, Lee's Summit, North Kansas City, Overland Park, Topeka
- Age
- 18 years and over
- People
- 50
- Run by
- University of Kansas Medical Center
See details and how to joinNCT04992780 - Phase 2Taking peopleCPI-613 (Devimistat) in Combination With Hydroxychloroquine and 5-fluorouracil or Gemcitabine in Treating Patients With Advanced Chemorefractory Solid Tumors
- Where
- Chicago
- Age
- 18 years and over
- People
- 94
- Run by
- Northwestern University
See details and how to joinNCT05733000 - No phaseTaking peoplePredicting Responsiveness in Oncology Patients Based on Host Response Evaluation During Anti Cancer Treatments, Using Multiomics
- Where
- Dallas
- Age
- 18 years and over
- People
- 350
- Run by
- OncoHost Ltd.
See details and how to joinNCT05736029 - No phaseTaking peopleI3LUNG: Integrative Science, Intelligent Data Platform for Individualized LUNG Cancer Care With Immunotherapy
- Where
- Chicago
- Age
- 18 years and over
- People
- 2,200 worldwide
- Run by
- Fondazione IRCCS Istituto Nazionale dei Tumori, Milano
See details and how to joinNCT05537922 - Phase 1Taking peopleFirst in Human Phase 1 Study of AG01 Anti-Progranulin/GP88 Antibody in Advanced Solid Tumor Malignancies
- Where
- Baltimore
- Age
- 18 years and over
- People
- 77
- Run by
- A&G Pharmaceutical Inc.
See details and how to joinNCT05627960 - Phase 1/2Taking peopleAssessment of Anti-tumor and Safety in Glumetinib in Patients With c-MET-positive Non-Small Cell Lung Cancer
- Where
- Louisville
- Age
- 18 years to 80 years
- People
- 183 worldwide
- Run by
- Haihe Biopharma Co., Ltd.
See details and how to joinNCT04270591 - No phaseTaking peopleThe Gut Microbiome and Immune Checkpoint Inhibitor Therapy in Solid Tumors
- Where
- Elizabethtown
- Age
- 18 years and over
- People
- 800
- Run by
- VastBiome
See details and how to joinNCT05037825